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Abstract 
Protein crystal production is a major bottleneck for the structural characterisation of 
proteins. To advance beyond large-scale screening, rational strategies for protein 
crystallization are crucial. Understanding how chemical anisotropy (or patchiness) of the 
protein surface due to the variety of amino acid side chains in contact with solvent, 
contributes to protein-protein contact formation in the crystal lattice is a major obstacle to 
predicting and optimising crystallization. The relative scarcity of sophisticated theoretical 
models that include sufficient detail to link collective behaviour, captured in protein phase 
diagrams, and molecular level details, determined from high-resolution structural 
information is a further barrier. Here we present two crystals structures for the P23T+R36S 
mutant of γD-crystallin, each with opposite solubility behaviour – one melts when heated, 
the other when cooled. When combined with the protein phase diagram and a tailored 
patchy particle model we show that a single temperature dependent interaction is sufficient 
to stabilise the inverted solubility crystal. This contact, at the P23T substitution site, relates 
to a genetic cataract and reveals at a molecular level, the origin of the lowered and 
retrograde solubility of the protein. Our results show that the approach employed here may 
present an alternative strategy for the rationalization of protein crystallization. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
The rationalisation of protein crystallization remains a major obstacle to efficient structure 
determination – a requirement to understand the molecular basis for many diseases and to 
pinpoint targets for new drug development [1]. Sampling hundreds (or sometimes 
thousands) of solution conditions (i.e. mixtures of different buffers, salts and precipitants) is 
often the most productive strategy to identify lead conditions for protein crystallization. 
Even when coupled with rational design strategies, such as surface entropy reduction (SER) 
[2], this approach, can be time-consuming and costly since screening methods often fail to 
produce crystalline material or diffraction quality crystals. Protein phase diagrams which 
map how a given protein behaves across sets of solution conditions dramatically improve 
the success of the process and narrow the screening required for producing diffraction 
quality crystals, but have only been measured for a small number of proteins [3 and 
references therein]. These reference studies have identified key challenges in guiding and 
improving protein crystallization. 
 
An excellent such reference is human γD-crystallin (HGD), a major structural protein found 
in the eye-lens. HGD is unusually stable in the eye lens in mixtures with α- and β-crystallins - 
often over a whole lifetime [4]. Its phase behaviour is otherwise very similar to that of a 
large a group of important globular proteins that includes haemoglobin [5], 
immunoglobulins [6], lysozyme [7], and thaumatin [8].  These phase diagrams are defined by 
net attractive short-range interactions that result in liquid-liquid phase separation and 
crystallization. Although native HGD itself does not readily form crystals, several of its 
genetic cataract-related single amino acid substitutions do so easily - without any major 
structural changes [9 - 14]. The P23T substitution which is a naturally-occurring mutation 
associated with congenital cataract however has unusual phase behaviour, in that its 
aggregates have inverted solubility, i.e. they melt as temperature is decreased [15, 16]. The 
protein is thus insoluble at physiological concentration and temperature, leading to eye lens 
opacity. In the related P23V mutant, both aggregates and crystals are observed, both also 
with inverted solubility [15, 16]. Yet, crystallization of the P23T mutant under physiological 
conditions has remained elusive.  Numerous structural and biophysical studies, including X-
ray structures at pH 4.5 and NMR solution studies, have failed to unambiguously identify 
major structural changes in the P23T mutant and hence a full explanation for its anomalous 
inverted solubility is still unknown [17 - 20]. 
 
Physico-chemical insights into protein phase behaviour – both normal and anomalous, are 
often gleaned from colloidal science. Simple colloidal models do capture key features of 
protein phase diagrams, such as their metastable critical point [21]. However, protein phase 
diagrams cannot be completely rationalised without including some level of anisotropy, in 
terms of the directional contacts between proteins in solution or within a crystal lattice [22 -
28] or of shape anisotropy [29]. This anisotropy gives rise to rich protein phase diagrams and 
is more widely exploited for the controlled assembly of biological and biomimetic materials 
[30]. It has even been proposed that these types of interactions are important in controlling 
liquid-liquid phase separation in cells [31], with important implications in understanding 
stress responses, RNA processing and gene expression.  However, understanding and 
predicting anisotropic protein-protein interactions ab initio is not yet possible, due to the 
extreme heterogeneity of amino acid side chains on the protein surface. While 
measurements indicative of net protein-protein interactions, such as the osmotic second 
virial coefficient, B22, or the diffusivity constant, kD, can provide some insight, they reflect 
the averaged pair interactions between proteins. These parameters are typically insufficient 
to trace back the specific, directional protein-protein interactions that control the dramatic 
(and often unpredictable) changes in protein assembly upon mutagenesis [14, 16]. 
Enhanced numerical models, that capture the details of anisotropic protein-protein 
interactions may allow for the prediction of protein phase diagrams and hence optimal 
crystallization conditions [17, 21-29, 32-35]. To identify the microscopic origin of inverted 
solubility, however, we need high-resolution structural information detailing the underlying 
anisotropic interactions, using for instance crystal structures of the protein of interest.  
 
To design a P23T mutant that crystallizes at pH 7, we focussed our interest on HGD mutant 
structures that do not form specific protein –protein contacts near proline 23. One such 
mutant, R36S readily crystallizes by forming a crystal lattice contact at position 36. By 
combining the R36S and P23T substitutions we reasoned that crystals of the double mutant 
would display inverted solubility, based on a comparison of the phase diagrams for the 
single mutant proteins, thus providing insights into the mechanism for the P23T mutant 
retrograde solubility. Remarkably, the double mutant, P23T+R36S, formed two distinct 
crystals forms - one with normal solubility and one with inverted solubility [36]. While 
inverted solubility in proteins has been previously observed, a protein that forms two 
distinct crystal lattices, each with opposite temperature dependence of the solubility line, 
had not and therefore this double mutant offers a rare opportunity to access the 
microscopic origin of solubility inversion, which we now probe further. 
 
Here we report the X-ray structures of the two crystal forms of the P23T+R36S mutant of 
HGD. We find that the two are polymorphs with different unit cells and crystal contacts and 
that it is possible to interchange between them by solely varying the solution temperature.  
In the inverted solubility crystal, a lattice contact involving the cataract-associated Thr23 
residue is formed. This is a new contact with the same binding energy determined from a 
statistical mechanics analysis of the chemical potentials of the solubility lines in earlier work 
[16]. We have used both the phase diagram for P23T+R36S and crystal structures to design a 
custom patchy particle model which incorporates specific contacts formed in the crystal 
lattice. We find that when temperature dependent patchy interactions are included, the 
temperature dependence of the solubility lines for both crystal lattices can be reproduced 
by simulations performed using the custom model. Specifically, we show that a change to 
the contact that contains the 23rd residue in the inverted solubility crystal is sufficient to 
cause inverted solubility. This contact becomes engaged as temperature increases, 
stabilising the inverted solubility crystal phase, thus revealing the molecular origin of the 
inverted solubility for P23T.  
 
Results and Discussion 
The equilibrium phase diagram for P23T+R36S is shown in figure 1 [36]. Two different crystal 
types are observed, distinguished by the temperature-dependence of their respective 
solubility lines; one with normal solubility (DBN), which melts as temperature increases and 
a second with inverted solubility (DBI), which forms at higher temperatures and melts as 
temperature is lowered. The solubility lines intersect at ≈ 303 K, where both crystal forms 
coexist. Remarkably, the two crystals form under near physiological conditions of 
temperature, pH and salt, unlike the previously determined structure of P23T (pH 4.6, 
PEG4K) [20].  
The crystals have different morphologies; DBN crystals are rod shaped and DBI crystals are 
rhombic. The proteins remain in their fully-folded globular state across the temperatures 
probed in this work. We further showed in previous work that this mutant protein displays 
no significant change to its secondary structure relative to native HGD. Our determination of 
the structures for these two crystal forms by X-ray crystallography confirms this finding for 
these polymorphs. 
 
Figure 1: Phase Diagram for P23T+R36S mutant of human γD-crystallin, indicating the equilibrium phase 
boundaries for the two crystals formed and their respective fluid phases. The volume fraction (𝜙) is calculated 
as 𝜙 = 𝑐. 𝜐𝑠𝑝, where c is the concentration of protein in mg/ml and νsp = 7.1 x 10
-4 mg/ml [16]. Coexistence of 
the two crystals is observed the temperature at which the phase boundaries overlap (~303K). 
The DBI (PDB ID: 6ETC) and DBN (PDB ID: 6ETA) structures consist of paired homologous 
domains that each adopt a Greek key motif.  DBI crystallized as a monomer at high 
resolution (1.2 Å), while DBN crystallized with two molecules in the asymmetric unit at 
medium resolution (2.2 Å).   
The overall structures of DBN and DBI are otherwise highly conserved, with an RMSD of 0.44 
Å for the main chain atoms (residues 1-173).  The side chain of Thr23 in DBI is involved in a 
crystal contact, within which it forms a hydrogen bond to the backbone of Gly129 in a 
symmetry-related molecule (figure 2a).  This interaction is unique to DBI as Thr23 is not 
involved in lattice contacts of DBN.  These polar interactions unambiguously demonstrate 
that the pathogenic P23T mutation enables direct interactions in the crystal lattice.  By 
contrast, Ser 36 is not involved in any direct contact in the DBI crystal (figure 2b). It only 
contributes a hydrogen bond within a DBN crystal contact. 
 
 
Figure 2:  (a) Interactions between Thr23 and the crystal lattice.  The side chain of Thr23 (gold) forms  a 
hydrogen bond with the backbone of NH of Gly128, indicating the close contacts between the P23T locus and a 
symmetry-related molecule; (b) Crystal contacts near the R36S locus of DBI.  Ser36 does not make direct 
contacts in the crystal lattice.  However, the side of Ser36 makes a hydrogen bond with Asp61, which makes 
salt bridges Arg139 in a symmetry related molecule. 
If we are to relate our findings to the P23T single mutant, it is reasonable to ponder if the 
P23T+R36S mutant is a good model for it. The R36S contact is not activated in DBI 
suggesting that it does not influence the structure of the DBI crystal to any significant extent 
and the DBN crystal is has the same structure and lattice contacts as the R36S single mutant. 
Because P23T and R36S reside on opposite sides of the N-terminal domain, we expect the 
structural and energetic influence of the two to be uncoupled.  The molecular interactions 
at the 36 locus are also distinct.  In the structures of DBN and the R36S single mutant (PDB 
ID: 2G98) [12], Ser36 forms a hydrogen bond with Asn24 with a symmetry mate in the 
lattice.  In contrast, DBI forms an intramolecular hydrogen bond with Asp62, which in turn 
ion-pairs with Arg140 in a symmetry-related molecule.  Thus, Ser36 in DBI orients Asp62 
lattice interactions, which is distinct from DBN.   
There is a significant degree of flexibility in the C-terminal domain of DBN (molecule B), 
which likely explains why only a medium resolution structure could be obtained as 
evidenced by the associated B-factors (Table 1). Other HGD mutants with medium 
resolution structures, namely the P23T (PDB ID: 4JGF) [20] and R36S (PDB ID: 4JGF) [12] 
single mutants, indeed display comparable flexibility in the C-terminal domain. By contrast, 
the corresponding domain in the DBI crystal is more rigid. It has a crystal contact formed by 
Ser173 (O) and the backbone NH of Gly157 of a symmetry-related molecule (figure 3A), 
which is associated with the higher-resolution structure.  Strikingly, the C-terminal 
carboxylate forms an ion-pair with Arg141 from the same symmetry mate.  There are also 
non-polar interactions between Phe172 and Gln67 from a second symmetry-related 
molecule, indicative of the intimate associations between the C-terminus of DBI in the 
crystal lattice. It is not clear, however, whether this flexibility is a result of a lack of a 
stabilizing crystal contact, or whether, conversely it precludes contact formation. 
 
 
Figure 3:  (A) Interactions at the C-terminus of DBI (gold).  DBI is green and symmetry-related molecules are 
grey and teal, respectively. (B) Flexibility of the C-terminal domain of DBN. The two ribbon models (A and B) in 
the asymmetric unit are annotated by gradient colours of backbone B-factors.  Region with high values 
indicating flexibility are red, while ordered regions are white. 
 
The formation of a hydrogen bond between Thr23 and the backbone of Gly129 in DBI 
suggests a molecular basis for a change in protein-protein interactions in the region of 
position 23 in the mutant protein. The change in the net binding energy between native 
HGD and P23T single mutant protein calculated from the solubility data [16], corresponds to 
approximately 2.4 kBT, which is indeed the strength of a typical hydrogen bond. Beyond this 
observation, there is no obvious structural basis for the inverted temperature dependence 
of the solubility line. Therefore, we employed a modelling strategy, based on custom patchy 
particle colloidal models to investigate the microscopic origins of the inverted solubility of 
the double mutant. 
The model describes proteins as having a hard spherical core with directional, short-ranged 
attractive patches representing crystal contacts, derived from the crystal structures (see SI). 
DBI and DBN are modelled with five contacts each (figure 4, see SI for details, including the 
amino acids involved in the different contacts). Despite its very crude description of protein-
protein interactions, such models can recapitulate the characteristic topology of protein 
phase diagrams. Because solubility inversion necessarily implies some degree of 
temperature dependence for the patch interactions [36], we first consider deactivating the 
contact that contains the 23rd residue, where the new crystal contact is formed, around a 
temperature Ta with rate τ, set by the experimentally observed inverted solubility 
temperature and density ranges, respectively. 
 
 
Figure 4: Crystal structures of DBI and DBN (right) are used to devise patchy particle models (centre). Patches 
derive from crystal contacts and each of them is represented here by a different colour (see table S1). A black 
dot specifically denotes the mutated 23rd residue. The resulting DBI (red) and DBN (blue) solubility lines 
obtained by deactivating the contact containing the 23rd residue  below temperature Ta intersect at the nearby 
triple point temperature, 𝑇𝑡𝑝, in near quantitative agreement with experimental observations. 
Simulations of this model with specialized Monte-Carlo methods determined the 
equilibrium phase diagram shown in figure 4. Upon cooling, the model solubility line for DBI 
crystals reaches a minimal volume fraction, 𝜙~10−4, before exhibiting an inverted solubility 
behaviour, and then the DBI crystal phase quickly disappears, all in remarkable agreement 
with experimental observations. The DBN solubility line, which shows normal solubility, 
afterwards intersects with that of the DBI crystal around 𝜙~10−3, forming a triple point. 
Experimental results are also suggestive of a triple point for comparable densities, but the 
flatness of the DBI solubility line in this regime precludes its accurate determination. Note 
that although similarly deactivating a larger set of DBI patches can also reproduce the 
observed experimental phase behaviour, no microscopic basis exists for these changes, and 
doing so to more than a couple of patches melts the crystal before solubility inversion can 
be observed. Prior experimental observations suggest that a change to surface 
hydrophobicity using either small molecule dyes [32] or by mutagenesis at position 23 [37] 
may give rise to entropic gain upon crystallization and could explain the lowered solubility of 
the mutant protein. Our results are consistent with this proposal.  
In our model, although the crystal state energy of DBI is significantly lower than that of DBN, 
this difference is largely offset in the inversion regime by the pressure-volume contribution 
that arises from the packing fraction difference between the two crystal forms and from the 
entropy difference associated with the different constraints on the crystal forms. The 
resulting chemical potential difference between the two crystal forms is then sufficiently 
small for DBI to become more stable than DBN upon activating a single patch. The solubility 
is inverted simply because activating the crystal contact that includes the 23rd residue 
substantially increases the stability of the DBI crystal.  This analysis thus confirms that local 
changes around the mutated residue alone can give rise to the observed inverted solubility, 
and that few other explanations are physically reasonable. 
 
Methods  
Preparation and characterisation of double mutant 
The double mutant was created, expressed and purified as described previously [36]. SDS-
PAGE and size exclusion HPLC were used to confirm protein purity at >98%. The intact 
molecular weight for the mutant protein was analysed by electrospray ionization mass 
spectrometry (Finger Prints Proteomics Facility, College of Life Sciences, University of 
Dundee), which confirmed molecular mass of 20,541 ±1 Da for P23T+R36S mutant.  
 
Crystallization and data collection 
The crystals were from the P23TR36S double mutant of human γD-crystallin protein were 
obtained and grown in grown in capillaries in 100mM Sodium Phosphate buffer (pH 7) in the 
presence of 20mM DTT. The solution concentration of protein was in the range of 1-2 
mg/ml and there was no additional precipitant in the solution. Crystals of the double mutant 
with inverted solubility (DBI) were grown at 310K, while crystals with normal solubility 
(DBN) grew at 277K. Crystals were harvested from capillaries and mixed with 25% glycerol, 
flash-cooled in liquid nitrogen and subjected to X-ray diffraction.  Data were collected at the 
PX2 beamline at Le Soleil Synchrotron, on an ADSC Q315 detector.   
Solubility measurements 
Protein solutions were prepared initially by diafiltration against 100mM sodium phosphate 
buffer, pH 7.0 using Ultracel 10KDa ultrafiltration discs (Merck Millipore, Co.Cork, Ireland). 
Protein concentrations for the double mutant was measured by UV absorbance using the 
extinction coefficient value of 2.09 mg-1 ml cm-1 after filtration through 0.22μm Millex-GV 
Millipore (Merck Millipore, Co.Cork, Ireland) syringe driven filters. When required, protein 
solutions were further concentrated by ultrafiltration using Amicon Ultra-4 centrifugal filter 
units (Merck Millipore, Co.Cork, Ireland) and the protein concentration re-established by UV 
absorbance. 
 
Data processing and structure solution 
The structure of DBN was solved using the model that contains the R36S single-site 
mutation in human γD-crystallin (PDB ID: 2G98) [38]. The program Phaser [39] provided the 
starting model, which was improved through cycles of manual model-building using Coot 
[40] and Phenix refinement [41].  The structure of DBI was solved using the high-resolution 
1.25Å structure of wild-type human γD-crystallin (PDB ID: 1hk0 [13]). The obtained structure 
was further refined using the same refinement procedure as in DBN.  Statistics from the 
data collection and refinement strategies are detailed in Table 1.  Crystal contacts 
determined from the structural analysis were used to determine the patch-patch 
interactions for the phase diagram, as described below. 
Description of the Model 
Since transitions between the two crystal forms occur upon temperature change, we 
consider the phase behaviour of the double mutant using a patchy particle model with 
temperature-dependent patches. This choice accounts for the associated change in bonding 
free energy [16]. 
Model Definition 
Proteins are modelled as patchy particles with interactions adapted from the Kern-Frenkel 
model [42]. Hard spheres (HS) with a diameter σ, chosen as the largest centre of mass 
distance between protein-protein crystal contacts, interact with directional, attractive 
patches of range λ𝛼𝛽σ for each protein-protein contact 𝛼𝛽. The patch interaction potential,  
𝑢(𝑟𝑖𝑗, Ω𝑖, Ω𝑗) = 𝑢𝐻𝑆 + ∑ 𝑢𝛼𝛽(𝑟𝑖𝑗, Ω𝑖, Ω𝑗),
𝑛
𝛼,𝛽
 
thus includes a factorized attractive contribution, 𝑢𝛼𝛽 = 𝑣𝛼𝛽(𝑟𝑖𝑗)𝑓𝛼𝛽(Ω𝑖, Ω𝑗), that depends 
on interparticle distance, 𝑟𝑖𝑗, and particle orientations, Ω𝑖 and Ω𝑗. Its orientational 
component is  
 
𝑓𝛼𝛽 = {
1,   𝜃𝛼,𝑖𝑗 ≤ 𝛿𝛼 and 𝜃𝛽,𝑖𝑗 ≤ 𝛿𝛽 
0, otherwise
× {
1, 𝜓𝛼𝛽,𝑖𝑗 ∈ [𝜙𝛼𝛽 − 𝛥𝜙𝛼𝛽 , 𝜙𝛼𝛽 + 𝛥𝜙𝛼𝛽]
0, otherwise
 
 
where the first term ensures that patch vectors are facing each other (SI Fig. 1). The second 
restricts the torsion between the two particles (SI Fig. 2). Its radial component is a square-
well potential  
 
𝑣𝛼𝛽(𝑟𝑖𝑗) = {
−𝜀𝛼𝛽(𝑇),   𝜎 < 𝑟𝑖𝑗 < 𝜆𝜎
0,   otherwise
 
where 𝜀𝛼𝛽 is constant if the patch is not temperature-dependent, and otherwise has a 
modulated interaction: 𝜀𝛼𝛽(𝑇) =
?̃?𝛼𝛽
2
(1 + tanh (
𝑇 − 𝑇𝑎
𝜏𝛼𝛽⁄ )), [43]  which becomes 
deactivated below temperature 𝑇𝑎 over a rate set by 𝜏𝛼𝛽, thus capturing the change in free 
energy due to the effect of  proposed increase in hydrophobicity. Model parameters were 
determined from all-atom molecular dynamics simulations of all patches of DBI and DBN. 
(See SI for methodological details and model parameters.)  
Phase Diagram Determination 
The phase diagram of the schematic model is obtained by specialized Monte Carlo (MC) 
simulations: (i) the reference crystal free energies are obtained by integrating from an ideal 
Einstein crystal using the Frenkel-Ladd method [44]; (ii) the chemical potentials of the 
crystal phases as a function of temperature are obtained by thermodynamic integration 
along isobars from the reference in (i); (iii) fluid free energies are approximated using the 
second virial coefficient, B22, due to inefficiency of traditional MC sampling at low fluid 
densities (SI). Coexistence points between the fluid and crystal phases are determined from 
the intersection of chemical potential curves, and coexistence lines then are traced out 
using a Gibbs-Duhem integration scheme [45, 46].  
 
Conclusions 
The rational design of a double mutant based on phase diagrams of single mutant proteins  
has allowed us to produce two crystal forms of the P23T+R36S mutant of HGD, that are  
polymorphs with different unit cells and distinct crystal contacts. The use of a single amino 
acid substitution (R36S) previously shown to increase the crystallization propensity of HGD 
but which is unrelated to the mutant under consideration (P23T) is not standard but could 
provide an alternative design strategy to assist large-scale crystallization screening. The 
crystal displaying inverted solubility (DBI) forms a hydrogen bond at position 23, which 
distinguishes it from other gamma crystallin structures. Employing crystallographic data for 
both crystals, further investigation of the microscopic origin of inverted solubility and 
greater understanding of the solution behaviour of the P23T single mutant was possible. By 
considering a patchy particle model parameterized for this particular system, the phase 
diagram for the double mutant protein was reproduced by simulations. A single 
temperature-dependent contact, specifically the contact that includes the P23T mutation, is 
sufficient to explain the crystallization behaviour for the protein. Activation of the patch 
that contains this mutation was found to stabilize the inverted solubility crystal. This overall 
analysis illustrates that although non-covalent protein-protein interactions are far from 
trivial and thus challenging to predict, the combination model and experimental phase 
diagrams could be a productive approach to rationalize and provide support for future 
crystallization studies.  
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Table 1.  Data collection and refinement statistics. 
Statistics for the highest-resolution shell are shown in parentheses. 
*B-factors for the C-terminal domain of molecule B reveal significant domain flexibility 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DBI DBN 
Resolution range 44.01-1.197 (1.24 -
1.197) 
48.16 – 2.20 (2.277-2.20)   
Space group P 1 21 1  P 21 21 21 
Unit cell (Å) 44.02 31.70 52.50 90 
91.29 90 
54.04  82.10  106.25   90  90  90 
 
Total reflections 89029 (8455) 164792 
Unique reflections 45768 (4504) 24656 (2391) 
Multiplicity 1.9 (1.9) 6.7 
Completeness (%) 99.46 (99.03) 99.63 (98.03 
Mean I/sigma(I) 8.93 (1.22) 9.2 (1.4) 
Wilson B-factor 10.73 38.69 
R-merge 0.03956 (0.5534) 0.129 
R-meas 0.05595 (0.7827) 0.139 
R-pim 0.03956 (0.5534) 0.053 
Reflections used for R-
free 
1999 (190) 1233 (119) 
R-work 0.1493 (0.2662) 0.2304 (0.2993) 
R-free 0.1794 (0.2835) 0.2658 (0.3614) 
Number of non-
hydrogen atoms 
1687 2888 
  macromolecules 1479 2776 
  solvent 208 112 
Protein residues 173 341 
RMS(bonds) 0.013 0.025 
RMS(angles) 1.21 1.49 
Ramachandran favored 
(%) 
98.83 94.93 
Ramachandran allowed 
(%) 
1.17 4.18 
Ramachandran outliers 
(%) 
0.00 0.9 
Rotamer outliers (%) 1.85 0.69 
Average B-factor 14.98 56.9 
  macromolecules 13.30 57.26 
  solvent 26.91 47.89 
  chain A (DBN): 1-81 --- 40.16 
  chain A (DBN): 82-173 --- 40.81 
  chain B (DBN): 1-81 --- 51.48 
  chain B (DBN): 82-173 --- *101.38 
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Contacts and Amino Acids in Each Contact  
The amino acids involved in DBI crystal contacts are given in table S2 and those for DBN can be 
found in table S3. The mapping of these amino acids on the protein surface are shown for 
different contacts in figure 4 of the manuscript. 
 
Table S2 List of amino acids in DBI crystal contacts. The residues shown in bold are involved in a hydrogen bond or a salt bridge, 
as identified by the PISA server [13]. Mutated residues are marked with an asterisk. The colors in parentheses are key to figure 4 
in the manuscript. 
DBI contacts Amino acids within 5A of interface 
c1 (light blue) ASP38 
VAL37 
LEU71 
SER173 
PHE11 
GLN66 
GLN67 
MET69 
TYR138 
ARG139 
GLU134 
LEU135 
SER36* 
HIS65 
ASP64 
GLY60 
ASP61 
ALA63 
ARG58 
ARG59 
PHE172 
GLN12 
GLY140 
GLY10 
ARG9 
ARG167 
ARG162 
ARG168 
ARG141 
LEU53 
TYR62 
ASP107 
c2 (teal) SER30 
GLN100 
GLU7 
PHE115 
LEU29 
TYR28 
ASN118 
ARG114 
PHE117 
ARG116 
ASP113 
GLN112 
ARG14 
PRO27 
c3 (gold) TYR153 
GLN47 
ARG168 
GLY157 
THR159 
GLY85 
ILE170 
GLN154 
ARG152 
ARG59 
ASN160 
HIS87 
HIS83 
SER39 
ALA158 
TYR143 
PHE172 
SER173 
GLU106 
GLU127 
SER86 
ARG141 
SER84 
LEU53 
GLU46 
GLY52 
 
c4 (green) ASP155 
TYR150 
MET146 
HIS83 
GLY148 
GLU127 
ARG88 
ASN49 
TYR97 
GLN154 
TYR16 
ARG152 
ASN24 
VAL125 
GLU17 
SER19 
SER20 
HIS22 
ASP21 
ARG151 
GLY128 
SER129 
PRO147 
PRO48 
LEU126 
LYS2 
PRO27 
ASP149 
SER86 
SER84 
TYR50 
TYR28 
THR23* 
PRO82 
 
c5 (red) PHE104 
GLU103 
GLY99 
THR105 
ARG88 
ARG98 
MET101 
ARG90 
TYR92 
ARG94 
GLU93 
 
Table S3 List of amino acids in DBN crystal contacts. The residues shown in bold are involved in a hydrogen bond or a salt bridge, 
as identified by the PISA server. Mutated residues are marked with an asterisk. The colors in parentheses are key to figure 4 in 
the manuscript. 
DBN contacts Amino acids within 5A of interface 
cI (dark blue) ARG116 
GLY13 
GLN100 
GLU7 
GLN12 
GLY99 
ARG98 
ARG14 
ARG31 
ASP8 
 
cII (gold) ARG114 
ARG88 
ARG116 
GLN112 
GLN67 
GLY85 
TYR138 
ARG139 
ASN137 
ASP113 
GLY60 
ASP61 
HIS87 
ARG58 
ARG59 
THR105 
SER109 
ARG167 
GLU106 
GLU103 
GLU127 
SER86 
TYR62 
ASP107 
cIII (light blue) TYR150 
LEU71 
ARG88 
ARG116 
GLN112 
GLN66 
MET69 
CYS110 
TYR97 
TYR16 
ARG139 
GLU134 
LEU135 
TYR50 
SER19 
MET146 
LEU80 
ARG79 
THR23* 
HIS22 
ASP21 
ASN124 
PHE117 
ASN118 
PRO147 
LEU126 
ASP113 
GLY148 
ARG162 
GLU127 
ASP149 
HIS83 
TYR28 
SER20 
PRO82 
GLY140 
cIV (green) ARG151 
ASP155 
GLN100 
ASP149 
GLY99 
ARG98 
ASP96 
ARG94 
GLU93 
cV (red) GLY10 
ALA63 
GLN47 
ASP38 
TYR6 
ARG59 
THR23* 
ASN24 
GLN12 
ASN49 
ASP61 
SER36* 
TYR28 
THR4 
PHE11 
PRO27 
HIS22 
GLN26 
LYS2 
PRO48 
 
cVI (teal) ARG114 
GLN47 
LEU71 
THR105 
ASP73 
ASP113 
GLU46 
SER72 
ARG31 
GLU106 
 
cVII (red) GLY10 
ARG9 
GLN47 
GLN26 
TYR6 
PHE11 
ASN24 
GLN12 
PRO48 
TYR28 
ASN49 
PRO27 
LYS2 
SER36* 
ALA63 
THR4 
THR23* 
 
ASP61 ASP38 
 
Calculation of Model Parameters  
Model parameters are calculated from all-atom molecular dynamics (MD) simulations using 
Gromacs [1] (versions 5.1 and 2016). As input configuration, pairs of proteins were placed in 
their crystal contact conformation. The missing atoms and residues to the crystal structures 
were inserted and the resulting structure was placed in a simulation box along with water and 
salt. Because no force fields exist for sodium phosphate, sodium chloride in identical ionic 
strength was included. The key impact of this salt on protein-protein interactions is to tune the 
ionic strength, hence the net result is equivalent. In addition, DTT was not included because its 
dominant role is to prevent disulfide bonds from forming, which is in any case impossible in our 
classical MD simulations.  The simulation box was then relaxed by energy minimization followed 
by a short, 100 ps NPT simulation. Simulation parameters that are common to the various types 
of MD simulations are given in table S4. 
 
In order to parameterize the patchy model, the potential of mean force (PMF) was obtained for 
each crystal contact. by running umbrella sampling simulations. These simulations were 
prepared by first pulling one of the protein copies away from the reference protein, following a 
direction perpendicular to the contact interface. Meanwhile, the reference protein is kept fixed 
by restraining the positions of three or four alpha carbons, chosen such that they are 
approximately equally-spaced, are not coplanar, and are not too close to the contact interface. 
To prevent the pulled protein from rotating, x- and y-coordinates of the same set of alpha 
carbons were also restrained. Pulling is done with a harmonic spring with a spring constant of 
5000 kJ mol−1nm−2, at a rate of 0.01 nm per ps. Input configurations for the umbrella 
sampling are then generated from the resulting trajectory, and then relaxed with a 100 ps NPT 
simulation with the same harmonic constraints as in the pull simulation, before running 20 ns-
long trajectories. Force information is saved every 100 ps to generate the PMF with Weighted 
Histogram Analysis Method implemented within Gromacs [2]. 
 
The parameters for each patch were then determined as follows. Its square-well potential 
depth was chosen as the depth of the PMF from the well to the long-distance plateau. Its 
interaction range was calculated by matching its contribution to the second virial coefficient, 
𝐵22,𝛼𝛽, to that of the PMF hence 
 
𝐵22,𝛼𝛽 = −
1
2
4𝜋 ∫(𝑒−𝛽𝑈(𝑟) − 1)𝑟2𝑑𝑟. 
 
The interaction range is then found by 
 
𝜆𝛼𝛽 = (
3 ∫(𝑒−𝛽𝑈𝑃𝑀𝐹,𝛼𝛽(𝑟) − 1)𝑟2𝑑𝑟
𝑒𝛽𝜀𝛼𝛽 − 1
+ 1)
1/3
. 
 
An additional 20 ns simulation was performed to determine the patch width and the width of 
the torsion angle between two particles for each patch. For these simulations, one protein copy 
was fixed in place by restraining the same set of alpha carbons. The harmonic spring was active 
with the same strength, but the pull rate was set to zero and the center of mass distance was 
kept at the equilibrium distance. Snapshots saved every 10 ps were analyzed to determine the 
vector perpendicular to the protein-protein interface. The dot product of the average vector 
with instantaneous vectors were calculated, and their mean was chosen as cos 𝛿𝛼, the patch 
width. The width of the dihedral angles, 𝛥𝜙𝛼𝛽, is calculated from the same trajectory by 
applying the rotation of the protein copies to a reference vector and calculating the angle 
between the two planes defined by (i) the first rotated vector and the center of mass vector, 
and (ii) the second rotated vector and the center of mass vector (fig. 2). 
 
 
Figure 1 Sample pair of interacting patches (red) illustrating 
the various model associated parameters 𝛿𝛼, 𝛿𝛽, and 𝜆𝛼𝛽. 
Here, 𝑒?̂? and 𝑒?̂? point to the centers of patches α and β, 
respectively. If the particles are separated by less than λσ, 
they interact only if 𝑒?̂? ∙ ?̂?𝑖𝑗 = 𝑐𝑜𝑠 𝜃𝛼 ≥ 𝑐𝑜𝑠 𝛿𝛼 AND    𝑒?̂? ∙
−?̂?𝑖𝑗 = 𝑐𝑜𝑠 𝜃𝛽 ≥ 𝑐𝑜𝑠 𝛿𝛽  
 
Figure 2 Two overlapping patches interact when their 
orientation falls within the range of allowed dihedral angles. 
The dihedral, ψαβ, is the dihedral angle between vectors zI, D, 
and zJ, where zI is calculated by applying the rotation of 
particle I to a reference axis chosen such that it is not parallel 
to any patch vector. 
 
 
The resulting parameters that result from this procedure are as reported in table S5 for 
contacts labeled cY, where Y is a Roman numeral for DBN contacts, and an Arabic numeral for 
DBI contacts. Contact 2 (c2) of DBI and contact I (cI) of DBN were found to be very similar in 
terms of geometry and the nature of their interactions and were hence merged. Similarly, 
contact V (cV) and VII (cVII) of DBN are almost identical and were also merged. The widths, 
range of dihedral angles, and interaction ranges for some patches for DBN had to be slightly 
widened to accommodate the crystal geometry of the model (see Model Geometry section 
below for details). 
 
The model parameters obtained by all-atom simulations of the crystal structures give rise to 
patch free energies slightly higher than typical for protein crystal contacts, resulting in crystals 
remaining stable at unusually high temperatures. These patch free energies are nevertheless 
consistent with contact dissociation free energy estimates from the PISA server, it is therefore 
possible that some of the surface regions not considered as patches might have a slightly higher 
repulsion than estimated by the hard-core description. Because the qualitative picture that 
emerges from this analysis is only affected by relative patch strengths, however, this correction 
δ
α
δ
β
r
ij
e
α
e
β
θ
α
θ
β
λσ
is not qualitatively significant. To correct for this effect, the patch deactivation temperature, 
Ta=1.9, is thus chosen such that the minimum packing fraction of DBI in its solubility line is 
around 10-4, as in experiments. (Note that the unit of temperature is such that T=1 corresponds 
to 277K, the experimental crystallization temperature for DBN.) We thus choose τ=0.05 so that 
patch deactivation occurs over a temperature range of order 10K, again paralleling the 
experimental observation. The triple point temperature obtained from simulations is Ttp=1.89, 
slightly below Ta, and is used in the main text to correct at once for the slight overestimate of 
the patch energies compared with the experimental values. 
 
Table S4 MD simulation parameters common to all types of all-atom simulations performed with Gromacs for model parameter 
determination. 
Forcefield: Amber03 [3] 
Water model: TIP4P-EW [4] 
Temperature: 277K for DBN, 310K for DBI 
Temperature control: Nose-Hoover 
thermostat [5] 
Electrostatic method: PME [6] 
Coulomb radius: 1.4 nm 
van der Waals method: cut-off 
van der Waals radius: 1.4 nm 
Integration step: 2 fs 
Constraints: all bonds with Lincs [7] 
Energy minimization: steepest-descent 
Salt concentration: 160 mM of NaCl 
Pressure control: Parrinello-Rahman 
barostat 
  
Model Geometry 
A number of modifications were made to the crystal geometry and to the patchy model so as to 
accommodate the relevant crystal forms and to simplify the computations. Because the DBI 
structure unit cell is almost orthorhombic: α=90°, β=91.29°, γ=90° we approximated it as a 
purely orthorhombic crystal. This results in minor changes in patch locations, which were 
previously shown not to affect phase diagram topology [8]. The other key feature is that the 
protein is slightly ellipsoidal, while a patchy particle is perfectly spherical. For DBI, all protein 
copies in the crystal are aligned, hence shrinking the unit cell along the z-direction solves the 
problem. For DBN, however, the structure is more complicated because the long axis of some 
of the eight asymmetric unit cells are aligned either in the x- or in the y-direction, thus requiring 
a more significant compression of the crystal. As a result, both the protein crystal and the patch 
positions must be perturbed to remove clashes. In addition, contacts II, cIV, and cVI must be 
collocated, in order to satisfy the various bonding constraints. The final geometry of both 
crystal models is summarized in tables S6 and S7. Interestingly, dihedral constraints are here 
necessary to properly separate the crystal ground states within the energy landscape. 
 
Table S5 Patch parameters obtained from all-atom molecular dynamics simulations. Numbers in parentheses denote the 
modified values to adjust the crystal geometry. 
Contact cos 𝛿𝛼  cos 𝛿𝛽 ∆𝜙𝛼𝛽 (rad) 𝜀 (kBT) 𝜆 (𝜎) 
c1 0.956 0.963 0.07 21.5 1.025 
c2 0.972 (0.935) 0.984 (0.935) 0.21 6.3 1.1 
c3 0.992 0.994 0.14 10.3 1.06 
c4 0.997 0.997 0.06 15.8 1.025 
c5 0.947 0.966 0.13 6.0 1.037 
cI 0.972 0.981 0.21 4.9 (6.3) 1.06 (1.1) 
cII 0.998 (0.96) 0.999 (0.96) 0.06 (0.3) 8.7 1.05 (1.11) 
cIII 0.998 (0.95) 0.997 (0.95) 0.038 (0.2) 10.1 1.03 (1.1) 
cIV 0.970 (0.96) 0.937 0.24 (0.3) 4.3 1.14 
cV 0.995 (0.95) 0.989 (0.95) 0.10 (0.21) 18.8 (18.5) 1.06 (1.153) 
cVI 0.898 0.927 0.23 (0.3) 8.6 1.03 (1.11) 
cVII 0.991 (0.95) 0.998 (0.95) 0.10 (0.21) 18.2 (18.5) 1.06 (1.53) 
 
Table S6 Patch locations and dihedral angles. Because of geometric constraints of the DBN structure, contacts cII, cIV, and cVI 
are collocated. 
Contact ?̂?1 ?̂?2 ?̂?3 𝜙𝛼𝛽 
c1 0.6614 
0.6473 
0.6543 
-0.2853 
0.3667 
0.7068 
-2.2703 
c2/cI -0.9854 
0.9854 
0.0471 
-0.0471 
0.1101 
-0.1101 
0.0 
c3 -0.0141 
0.0141 
-0.9402 
0.9402 
0.3403 
-0.3403 
0.0 
c4 0.3231 
0.3089 
0.1911 
-0.7486 
-0.9269 
-0.5867 
-2.1288 
c5 -0.6474 
-0.6613 
0.2851 
-0.6543 
-0.7068 
-0.3669 
2.2698 
cII* -0.9494 
0.0011 
0.3101 
0.4334 
-0.0499 
0.9012 
-2.4946 
cIII -0.6455 
-0.7102 
-0.5123 
-0.5524 
-0.5665 
0.4365 
-1.80 
cIV* -0.9494 
0.0011 
0.3101 
0.4334 
-0.0499 
0.9012 
-2.4946 
cV/VII 0.3162 
0.4927 
-0.8026 
0.8531 
-0.5058 
0.1716 
-2.1529 
cVI* -0.9494 
0.0011 
0.3101 
0.4334 
-0.0499 
0.9012 
-2.4946 
 
Table S7 Geometry of DBI and DBN crystals for the patchy model. Lengths are in units of σ. The rotation of each particle is 
calculated from Euler angles reported as (α, β, γ) with the Rz(α)Rx(β)Rz(γ) convention, where Rz denotes a counterclockwise 
rotation through the z-axis and Rx a counterclockwise rotation through the x-axis. 
DBI 2 asymmetric units, unit cell: (√2, 1,1) 
 Particle position Particle rotation 
 0, 0, 0 -1.927, 1.349, -1.474 
 √2/2, 0.5, 0.5 1.927, 1.793, 1.668 
DBN 8 asymmetric units, unit cell: (1.02, 3.149,3.586) 
 Particle position Particle rotation 
 0.184, 0.470, 0.385 
0.183, 0.073, 3.061 
0.761, 1.024, 3.238 
0.647, 1.438, 0.631 
0.954, 2.030, 1.478 
0.032, 1.704, 2.446 
0.479, 2.623, 2.213 
0.537, -0.203, 1.167 
1.427, 1.681, 1.371 
1.096, 0.186, 5.375 
1.685, 1.547, 4.421 
2.043, 2.916, 2.222 
4.869, 1.420, 4.519 
4.876, 3.029, 1.923 
4.548, 1.581, 1.316 
3.468, 0.065, 6.046 
 
Phase Diagram Determination 
The phase diagram of the patchy particle model is computed by specialized MC simulations. In 
general, 200,000 MC sweeps each of which consists of N displacement and N rotational moves 
for constant NVT simulation and an additional two volume moves for NPT simulations. The 
amplitude of the displacements is chosen such that an acceptance rate around 50% is obtained. 
System sizes are chosen to be similar from one phase to the other, while respecting the crystal 
symmetry, here, 𝑁𝐷𝐵𝐼 = 432 and 𝑁𝐷𝐵𝑁 = 512. For convenience, these simulations report 
distances in units of 𝜎, and energies in units of 𝑘𝐵𝑇 with 𝑇 = 277𝐾.  
 
Crystal free energies were obtained by integrating from an ideal Einstein crystal, and then 
integrated along isobars to determine the free energy as a function of temperature. 
Thermodynamic integration along isobars is more numerically stable than over integration 
along isotherms because both crystals are strongly geometrically constrained, and thus a very 
low compressibility. For a system with temperature-dependent pair potential, the chemical 
potential of the system with respect to a reference system at 𝑇𝑜 is given by 
 
𝛽𝜇(𝑇, 𝑝) = 𝛽0𝜇(𝑇𝑜 , 𝑝) − ∫
𝐻(𝑇′)
𝑁𝑘𝐵𝑇′2
𝑑𝑇′ + ∫
<
𝜕𝑈
𝜕𝑇′
>
𝑁𝑘𝐵𝑇′
𝑑𝑇′
𝑇
𝑇0
,
𝑇
𝑇0
 
where 𝐻 is the enthalpy, and <
𝜕𝑈
𝜕𝑇
> is the ensemble average of the temperature derivative of 
the pair potential. 
 
Sampling the low density–low pressure regime of the phase diagram is numerically inefficient, 
hence in this regime, we estimate the fluid equation of state and free energy from the second 
virial coefficient: 
 
𝛽𝑝
𝜌
= 1 + 𝐵2𝜌, 
𝛽𝜇 = 𝛽𝜇𝑖𝑑 + 2𝐵2𝜌 = log 𝛬
3𝜌 + 2𝐵22𝜌, 
 
where 𝜇𝑖𝑑 is the chemical potential of the ideal gas, and the thermal de Broglie wavelength Λ is 
set to one without loss of generality. 
 
Coexistence points were obtained from the intersection of the crystal and fluid isobaric 
temperature-chemical potential curves. Solubility lines were then traced by numerical Gibbs-
Duhem integration [9] [10]. Both boxes were simulated for 200,000 MC sweeps for each 
temperature. The slope of the solubility line was corrected every 1000 MC sweeps. The 
temperature was propagated in steps of 𝛥𝛽 = 0.003. Note that introducing temperature-
dependent patches requires modifying the standard Clausius-Clapeyron equation [11] 
 
𝑑𝑃
𝑑𝑇
=
𝛥𝑒 + 𝑝𝛥𝑣 − 𝑇𝛥 〈
𝜕𝑢
𝜕𝑇
〉
𝑇𝛥𝑣
, 
 
where 
𝜕𝑢
𝜕𝑇
 is the derivative of the interaction energy with respect to temperature, the angular 
brackets denote an ensemble average. This additional term here allows for the crystal solubility 
curve to be inverted. (Typically, 𝑑𝑃 𝑑𝑇⁄  is positive because 𝛥𝑒 and 𝛥𝑣 tend to have the same 
sign.) At low fluid densities, only the crystal was simulated, while 𝑒𝑓 was calculated analytically 
 
𝑒𝑓 =
1
𝑁
(
𝑑(
𝐹
𝑇)
𝑑(
1
𝑇)
)
𝑁,𝑉
= 𝜌 (
𝜕𝐵22
𝜕𝛽
)
𝑁,𝑉
. 
 
The ensemble average of the interaction energy can be estimated by considering the average 
number of bonds active in the fluid, 𝑒𝑓/𝑒𝑡𝑜𝑡, where the denominator is the sum of all patch 
energies 
 
〈
𝜕𝑢
𝜕𝑇
〉𝑓 =
𝜌
𝑒𝑡𝑜𝑡
(
𝜕𝐵22
𝜕𝛽
)
𝑁,𝑉
𝜕𝑢
𝜕𝑇
. 
 
The second virial coefficient for our model is calculated as in Ref. [12] and is defined as 
 
𝐵22 = −
1
2𝑉
∫ 𝑑𝒓𝟏 ∫ 𝑑𝒓𝟐 ∫ 𝑑𝛀𝟏 ∫ 𝑑𝛀𝟐 ∫ 𝑑𝜒 (𝑒
−  𝛽𝑢(|𝒓𝟏−𝒓𝟐|) − 1), 
where the integration is performed over the particle positions, r, orientation (in terms of solid 
angles, 𝛀), and dihedral angle 𝜒 (see figure 2). Because cII, cIV, and cVI overlap in our patchy 
model, but do not have the same ranges or angular widths, we have 
 
  
𝐵22
𝐵22
𝐻𝑆
= 1 − ∑ (𝜆𝑖𝑗
3 − 1)sin2 (
𝛿𝑖
2
) sin2 (
𝛿𝑗
2
) (𝑒𝛽𝜀𝑖𝑗 − 1)(2𝛥𝜙𝑖𝑗)
− (𝜆𝐼𝑉
3 − 𝜆𝐼𝐼
3 )(𝑒𝛽𝜀𝐼𝑉 − 1) sin2 (
𝛿𝐼𝑉,𝛼
2
) sin2 (
𝛿𝐼𝑉,𝛽
2
) (2𝛥𝜒) − (𝜆𝐼𝐼
3 − 1)(𝑒𝛽(𝜀𝐼𝐼+𝜀𝐼𝑉+𝜀𝑉𝐼)
− 1) sin2 (
𝛿𝐼𝐼,𝛼
2
) sin2 (
𝛿𝐼𝐼,𝛽
2
) (2𝛥𝜒) − (𝜆𝑉𝐼
3 − 1)(𝑒𝛽(𝜀𝐼𝑉+𝜀𝑉𝐼)
− 1) sin2 (
𝛿𝐼𝑉,𝛼
2
) sin (
𝛿𝐼𝑉,𝛽 + 𝛿𝐼𝑉,𝛼
2
) sin (
𝛿𝐼𝑉,𝛽 − 𝛿𝐼𝑉,𝛼
2
) (2𝛥𝜒)
− (𝜆𝑉𝐼
3 − 1)(𝑒𝛽𝜀𝑉𝐼
− 1)(2𝛥𝜒)[sin2 (
𝛿𝐼𝑉,𝛼
2
) sin (
𝛿𝐼𝑉,𝛼 + 𝛿𝐼𝑉,𝛽
2
) sin (
𝛿𝐼𝑉,𝛼 − 𝛿𝐼𝑉,𝛽
2
) +sin (
𝛿𝑉𝐼,𝛼 − 𝛿𝐼𝑉,𝛼
2
) sin (
𝛿𝑉𝐼,𝛼 + 𝛿𝐼𝑉,𝛼
2
) sin2 (
𝛿𝑉𝐼,𝛽
2
)] 
where 2𝛥𝜒 = 0.6, the width of the range of valid dihedral angles, is the same for all three 
patches. 
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